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Purpose: We aimed to quantify atrial and ventricular myocardial deformation in Ebstein's Anomaly (EA) in a
case-control study with cardiovascular magnetic resonance (CMR) feature tracking and to correlate changes in
cardiac performance with the severity of disease and clinical heart failure parameters.
Materials andmethods:Atrial and ventricular deformationwasmeasured using CMR feature tracking in 30 EA and
20 healthy control subjects. Atrial performance was characterized using longitudinal strain and strain rate
parameters for reservoir function, conduit function and booster pump function. Ventricular performance
was characterized using RV and LV global longitudinal strain (εl) and LV circumferential and radial
strain (εc and εr). Volumetric measurements for the ventricles including the Total Right/Left-Volume-Index
(R/L-Volume-Index) and heart failure markers (BNP, NYHA class) were also quantiﬁed.
Results: EA patients showed signiﬁcantly impaired right atrial performance, which correlated with heart failure
markers (NYHA, BNP, R/L-Volume-Index). LA function in EA patients was also impaired with atrial contractile
function correlating with NYHA class. EA patients exhibited impaired RV myocardial deformation, also with a
signiﬁcant correlation with heart failure markers.
Conclusion: CMR feature tracking can be used to quantify ventricular and atrial function in a complex cardiacmal-
formation such as EA. EA is characterized by impaired quantitative right heart atrio-ventricular deformation,
which is associated with heart failure severity. While LV function remains preserved, there is also signiﬁcant
impairment of LA function. These quantitative performance parameters may represent early markers of cardiac
deterioration of potential value in the clinical management of EA.
© 2017 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
Keywords:
Ebstein's Anomaly
CMR
Feature tracking
Strain
R/L-Volume-Index
Heart failure
1. Introduction
Ebstein's Anomaly (EA) of the tricuspid valve (TV) accounts for
approximately 0.5% of congenital heart disease (CHD) patients. Many
EA patients suffer from progressive right heart failure and impaired
physical exercise capacity at some stage in their life [1,2]. The patho-
physiology comprises a dysplastic and tethered TV displaced towards
the right ventricular (RV) apex with subsequent “atrialization” of the
RV (aRV), higher grade tricuspid valve regurgitation (TVR) and RA and
RV volume overload [3]. Additionally, deterioration of LV function is
frequently observed in EA [4,5]. To date, the pathophysiological changes
that ultimately cause progression to global heart failure in EA are
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unknown. Moreover there is a lack of biomarkers of clear clinical value
that indicate cardiac deterioration at an early stage in EA.
The clinical relevance of impaired atrial function in heart failure
development is increasingly recognized [6]. Right atrial (RA) function
has been studied in some congenital heart disease (CHD) [7,8] using
echocardiography and CMR [9]. Both echocardiography and CMR-FT
are equally able to discriminate left and right atrial phasic performance
based on strain (ε) and strain rate (SR) imaging [10–12]. The reservoir
phase, characterized by collection of pulmonary venous return during
ventricular systole can be quantiﬁed by global peak longitudinal total
strain (εs) and global peak positive SR (SRs). The conduit phase that
describes the passage of blood to the ventricle during early ventricular
diastole is indicated by global longitudinal passive strain (εe) and
global peak early negative SE (SRe). The contractile phase or booster
pump function describes the intensity of atrial contraction resulting in
augmentation of ventricular ﬁlling during late ventricular diastole
and can be quantiﬁed measuring global longitudinal active strain (εa)
and global peak late-negative SR (SRa) during atrial contraction [12].
These parameters have been studied in non-symptomatic participants
of the Multi-Ethnic-Study of Arteriosclerosis [13,14] demonstrating
prognostic value in heart failure prediction and in patients with atrial
ﬁbrillation showing a close link to stroke occurrence.
Alterations in atrial function – which reﬂect changes in myocardial
deformation itself but are also dependent on RV function, loading
conditions and tricuspid regurgitation – may possibly represent early
markers for deterioration of overall cardiac function, but have not
been deﬁned in EA [11]. Also the interplay of atrial and ventricular
performance of the right and left heart may play a role in EA disease
progression. Thus, we sought to assess atrial and ventricular function
in EA using a comprehensive CMR protocol and myocardial FT analysis.
Moreover, we aimed to correlate changes in biatrial and biventricular
performance with the severity of EA and clinical parameters of
heart failure.
2. Methods
2.1. Study population
From a total of ﬁfty-eight patients with EA in the database of the Department of
Pediatric and Adult CHD, University Medical Center Göttingen, Germany, 31 patients
with EAwere prospectively recruited in this case-control study and gavewritten informed
consent to participate. Exclusion criteria included age b 10 years, implantable electronic
cardiac devices, associated complex cardiac malformations and claustrophobia. The 31
patients (21 male) were examined prospectively within one day between January 2013
and July 2013 and compared to 20 healthy matched controls (10 male). Six of the EA
patients had undergone previous cardiac surgery (2 Glenn-Anastomosis, 2 TV recon-
structions, one TV replacement and one patient with both, a TV reconstruction and
Glenn-Anastomosis). Seven of eight patients with atrial septum defect (ASD) had
undergone ASD closure (3 interventional, 4 surgical). Sinus rhythm was documented
during the examination and no higher degree AV blocks were noted. The study
protocol included medical history, New York Heart Association (NYHA) classiﬁcation,
clinical examination, brain natriuretic peptide (BNP) and CMR. The study protocol
complied with the Declaration of Helsinki and was approved by the local clinical
ethics committee.
2.2. CMR imaging
CMR was performed according to current guidelines [15]. All CMR measure-
ments were performed at a 1.5 Tesla MRT-“Symphony“-scanner (Siemens Medical
Systems, Erlangen, Germany). All patients were examined according to a standard-
ized imaging protocol for EA and without sedation. A 16 channel phased-array-
receiver coil was used for signal reception. Ventricular dimensions and function
were assessed using stacks of multislice-multiphase steady state free precession
cine images in ventricular short-axis as well as in axial orientations. Standard
imaging parameters were as follows: repetition time = 44 ms, echo time =
1.3 ms, ﬂip angle = 20°, slice thickness = 5 mm, spatial resolution 1.6 × 1.6 mm;
parallel imaging acceleration factor 2; 12 s breath hold; with retrospective
gating. Pulmonary artery ﬂow was measured using phase contrast through-plane
measurements in the main pulmonary artery just above the pulmonary valve
and then used to calculate the TVR with the equation introduced by Fratz
et al. ðTR ¼ ð fRVSV−PAantefRVSV−PAretroÞ  100Þ [16].
2.3. Feature tracking
Myocardial FT was performed using dedicated software (TomTec Imaging Systems,
2D CPA MR, Cardiac Performance Analysis, Version 1.1.2.36, Unterschleissheim,
Germany). Results are based on averaging of three repeated measurements by the same
observer to maximize reproducibility as previously demonstrated [17].
2.4. Atrial feature tracking analysis
The 4-chamber view showing all 4 cardiac chambers was used to calculate LA and RA
strain and strain rate [18]. As the anatomy can vary signiﬁcantly in EA patients this will be
referred to as the horizontal long axis view in the course of this manuscript. Atrial
endocardial borders were manually drawn using a point-and-click approach at the end
of ventricular diastole representing the time of the lowest atrial ﬁlling. Atrial borders of
the anatomical RA were tracked at the site of the true tricuspid annulus from the lateral
wall to the septal RA wall. We thereby excluded the atrialized portion of the RA, which
is marked by the displaced tricuspid valve and could not be tracked. After the automated
tracking algorithmwas applied, tracking performance was visually controlled and, in case
of insufﬁcient border tracking, manually corrected and the algorithm reapplied. In case
of persisting insufﬁcient tracking quality, the corresponding segment was excluded from
the analysis.
The three main components of atrial physiology were quantiﬁed as follows (Figs. 1A
and B): 1) atrial reservoir function representing the collection of venous return during
ventricular systole using total strain (RA εs/LA εs) and peak positive strain rate (SRs), 2)
atrial conduit function representing the passage of blood to the ventricles during early
ventricular diastole using passive strain (RA εe/LA εe) and peak early negative strain
rate (SRe) and 3) atrial contractile booster pump function representing the augmentation
of ventricular ﬁlling during late ventricular diastole using active strain (RA εa/LA εa) and
peak late negative strain rate (SRa) [6].
2.5. Ventricular analysis
Ventricular strain was calculated from horizontal long axis and short-axis slices as
previously described [19]. The horizontal long axis was used to quantify endocardial RV
and LV global longitudinal strain (RV εl/LV εl). In order to calculate global circumferential
and radial LV short-axis strain (LV εc and LV εr), endo- and epicardial contours, were
drawn on basal, mid-ventricular and apical short-axis slices. Global LV εc was calculated
as average from subendocardial and subepicardial LV εc.
Volumetric analysis was performed with commercially available software (QMass,
Medis, The Netherlands). For EA patients the functional right ventricle (fRV) was used
for RV measurements and contours were drawn to the insertion of the displaced TV leaf-
lets. For ventricular volumetric analysis, endocardial contours for RV and LVwere drawn in
all short axis slices at end systole and end diastole. Short axis orientation was employed
deliberately since previous work has demonstrated similar results for short axis and
transverse quantiﬁcation of ventricular function [20], as well as to ensure comparability
between EA patients and healthy volunteers. EF was calculated from end diastolic volume
indexed to BSA (EDVi) and end systolic volume indexed to BSA (ESVi).
The Total Right/Left-Volume-Index (R/L-Volume-Index) as a clinical severity parame-
ter of EA was calculated from end diastolic volume measurements ðR=L‐Volume‐Index ¼
RAþaRVþ fRV
LAþLV Þ [20].
2.6. Statistical analysis
Statistical analysis was performed using Microsoft Excel (Microsoft Corporation,
Redmond, Washington, USA), Statistica (Stat Soft, North Melbourne, Australia) and IBM
SPSS Statistics version 22 (IBM Corporation, Armonk, New York, USA). Data are expressed
as mean (±standard deviation). After assessment for normality using the Kolmogorov-
Smirnov test, the data were compared using a t-test and the Mann-Whitney-U test for
parametric and non-parametric data, respectively. Spearman's correlation coefﬁcients
were calculated for relations between functional indexes and heart failure parameters
and for relations between the functional indexes of atria and ventricles. A sub-group
analysis was performed after exclusion of EA patients with previous corrective surgery
(24 patients left).
Measurements were performed by two independent skilled observers. The ﬁrst
observer (M.B) analysed all data based on average curves of three analyses repetitions
and repeated the analyses of the functional atrial parameters in 10 randomly selected
subjects after a period of 4 weeks for the intra-observer variability. The second observer
(J.T.K.) performed the analysis in the same 10 subjects for the analysis of the inter-
observer variability. Reproducibility was assessed using the coefﬁcient of variation [21]
and the method described by Bland and Altman [22]. Due to multiple comparisons,
p-values for Spearman's correlation were reported for descriptive purposes. For all other
comparisons, p-values b 0.05 were considered statistically signiﬁcant.
3. Results
CMR-FT was successfully performed in 30 patients with EA and all
controls. One patient with EA was excluded due to insufﬁcient image
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quality from motion artifacts. The mean age of the EA patients was
26.3 years (controls 23.7 years, p= 0.238).
Overall, 85.3% of the atrial segments were included in the EA group
and 94.6% in the control group. Exclusion of atrial segments was
predominantly associated with poor tracking quality due to insertion
of pulmonary veins in the LA and poor imaging quality associated
with breathing motion.
3.1. Right atrial function
RA reservoir and booster pump function were signiﬁcantly reduced
in the EA group as compared to controls (Table 1). Conduit function
was signiﬁcantly lower in EA based on SRe, whilst there was a trend
towards reduction in εe derived conduit function (Table 1).
3.1.1. Correlation with heart failure markers
RA function exhibited correlations with heart failure parameters in
EA patients (see Table 2): 1) atrial reservoir function correlated signiﬁ-
cantly with BNP level (RA εs and SRs) and NYHA class (p b 0.05 for RA
εs; and a strong trend for RA SRs, p= 0.067); 2) atrial conduit function
(RA εe and SRe) correlated with the R/L-Volume Index; and 3) atrial
booster pump function (RA εa and SRa) correlated with NYHA class
and BNP (see Table 2).
There was no signiﬁcant correlation between RA deformation
parameters and the degree of TVR.
3.2. Right ventricular function
RV volume was higher, and RVEF and RV longitudinal strain (RV εl)
were signiﬁcantly lower in EA patients compared with healthy controls
(see Table 1).
3.2.1. Correlation with heart failure markers
RV volume and RVEF correlated with the R/L-Volume Index. RV εl
correlated with all heart failure parameters (R/L-Volume Index, NYHA
class, BNP) (see Table 2).
3.2.2. Atrio-ventricular coupling
Atrio-ventricular coupling analysis revealed correlations of RV εl
with atrial reservoir and conduit function (see Table 3).
3.3. Left atrial function
EA patients had decreased LA reservoir (εs) and conduit function
(εe, SRe) as well as reduced booster pump function (SRa) (see Table 1).
3.3.1. Correlation with heart failure markers
LA booster pump function showed a correlation with NYHA class
based on strain and SR, respectively (NYHA–LA εa r = −0.455,
p = 0.017 and SRa r = 0.455, p = 0.017).
3.4. Left ventricular function
There was a trend towards lower LV longitudinal strain (LV εl) in
EA patients compared to controls (p = 0.067), while LV volumetric
parameters did not differ between groups.
3.4.1. Correlation with heart failure markers
LV volumetric data correlatedwith NYHA class and the R/L-Volume-
Index (LVEF total–NYHA r=−0.411, p= 0.030 and EDVi–R/L Index
r =−0.491, p = 0.009).
3.5. Impact of cardiac surgery
The correlation of heart failure stages with both reservoir function
(NYHA, BNP) and booster pump function (NYHA) remained, irrespec-
tive of the exclusion of the patients who underwent corrective surgery
(data not shown). Conversely, the association of RA booster pump func-
tion and BNP could not be detected when looking at the EA subgroup
without previous cardiac surgery (p N 0.05).
Furthermore, cardiac surgery did not impact on the association of
the severity of EA (R/L-Volume-Index) and RA conduit function.
3.6. Inter- and intraobserver variability
Atrial strain and SRwere reproducible on an inter- and intraobserver
level with low values for mean difference and coefﬁcient of variation
(range 10.5 to 32.8 depending on individual parameter, supplementary
material supplied upon request).
4. Discussion
Our study describes a well-characterized, functional phenotype
based on atrial and ventricular mechanical function in EA. We demon-
strate that CMR-FT is a suitable technique for quantiﬁcation of cardiac
atrial and ventricular deformation in a complex congenital heartmalfor-
mation such as EA. We can show for the ﬁrst time, that in EA CMR-FT
derived RA and RV function, but to some extent also LA function,
was impaired and correlated with heart failure markers. Correlation
analysis of RA function with heart failure markers revealed the follow-
ing: 1) patients with more severe heart failure stages (expressed by
BNP and NYHA class) showed larger reduction of RA reservoir function
and RA booster pump function, and 2) patients with more severe EA
(as expressed by the R/L-Volume-Index) had lower values for RA
conduit function.
It is important to note, that these ﬁndings were independent of
previous cardiac surgery and are thus applicable to a heterogeneous
EA patient collective. Moreover, it is important to understand that RA
function is dependent on loading conditions and RV and tricuspid
valve function at the time of the exam. Changes in RA function are not
necessarily reﬂective of overall intrinsic atrial function alone.
Besides functional impairment of the RA, LA conduit function was
also affected to a lesser extent. Interestingly, whilst LA reservoir and
conduit function were lower as compared to control subjects only LA
booster pump function was related to heart failure severity as deﬁned
by NYHA. This is paralleled by association of reduced RA booster
pump function with NYHA class in our cohort. Similar to ﬁndings in
non-congenital left heart disease [23], this highlights the potential im-
portance of the active atrial contractile function in heart failure in EA.
4.1. Right heart function
Standard RV functional parameters derived from CMR including EF
and volumes do not correlate well with exercise capacity and heart
failure markers in EA patients [24]. A lack of correlation between RV
volumes and EF with NYHA and BNP was observed in the present
study, as well, but we identiﬁed a correlation of RV strain and several
RA metrics (Table 2).
Quantiﬁcation of RA function in CHD is receiving increasing interest
[25] and impaired RA function has been reported in congenital right
heart disease Tetralogy of Fallot (TOF) [26] or ASD [27]. Reduced
RA reservoir function and elevated conduit function occur in TOF
with higher grade pulmonary regurgitation and large RV EDVi [26].
In our cohort of EA, RA reservoir and booster pump function were
Fig. 1. A: Right atrial feature tracking in a patient with Ebstein's Anomaly and a healthy control. B: Left atrial feature tracking in a patient with Ebstein's Anomaly and a healthy control.
RA εl: right atrial longitudinal strain; LA εl: left atrial longitudinal strain; SR: strain rate.
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impaired and associated with higher NYHA class and increased BNP.
This is in line with observations in TOF patients [9].
The mechanism behind impaired RA deformation might be a higher
degree of RA preload (determined by a) central venous return and b) TR
induced volume load) and an unfavourable pre-dilation of atrial
myoﬁbres (Frank-Starling mechanism). Changes in atrial strain and
strain rate, as observed in our study, are reﬂective of contractility and
distensibility of the myoﬁbrils, i.e. possibly alterations in the optimal
Frank-Starling curve. A study of Ren et al. links changes in LA function
in patients with mitral regurgitation to the Frank Starling Mechanism
and atrial pre-load conditions [28]. This supports our hypothesis that
loading conditions and the Frank Starling mechanism play a role in al-
tered atrial function in EA. Since the atrialized RV contracts in synchrony
with the RV and thus against a closed TV, the degree of dyssynchrony of
the aRV and anatomical RA may be another contributor to changes in
the atrial contraction. This remains speculative, since aRV tracking is
not feasible with our technique.
RV function in EA patients was also compromised, as expressed
by impaired RV εl. Changes in RV εl depict changes in RV myocardial
contraction and are – comparable to RA function – dependent on
ventricular loading conditions. However, RV εl correlation with heart
failure markers suggest that these changes in deformation may be
clinically relevant.
Unifying the above observations, we hypothesized that cardiac
dysfunction in EA is linked to decreased RA deformation – possibly
based on a shift away from the optimal Frank-Starling curve – coupled
with impaired RV longitudinal function (i.e. reduced RV εl in the
EA group). Spearman analysis of RA–RV interaction in our cohort
conﬁrmed positive correlation of RV strain with RA reservoir and
conduit function and supports this hypothesis.
4.2. Left heart function
Our results show that LA function is also affected, albeit to a lesser
extent compared to the RA, while LV systolic function was normal.
Even though systolic LV function may be preserved in our collective,
LA reservoir and conduit function are reduced and may reﬂect LV
diastolic dysfunction. This hypothesis is in line with Inai's description
of diastolic dysfunction in EA with preserved LV EF [29].
4.3. Limitations
This was a single center cross sectional study. Our cohort only
comprises a small number of patients with higher degree heart failure
(NYHA III or IV), which is due to the low incidence of EA.
Table 1
Comparison of functional parameters of EA patients and healthy controls.
EA patients Controls P-value EA patients Controls P-value
Right atrium Left atrium
Reservoir function
Strain (εs (%)) 20.50 ± 9.91 28.79 ± 10.86 0.009 17.81 ± 9.45 21.06 ± 5.79 0.037
Strain rate (SRs (/s)) 0.96 ± 0.35 1.20 ± 0.42 0.037 0.74 ± 0.31 0.89 ± 0.27 0.094
Conduit function
Strain (εe (%)) 14.31 ± 7.93 18.29 ± 8.85 0.094 13.14 ± 7.95 15.28 ± 5.30 0.040
Strain rate (SRe (/s)) −0.65 ± 0.29 −0.90 ± 0.42 0.021 −0.76 ± 0.38 −1.08 ± 0.44 0.007
Booster pump function
Strain (εa (%)) 6.19 ± 4.88 10.49 ± 5.27 0.006 4.67 ± 3.38 5.78 ± 3.76 0.300
Strain rate (SRa (/s)) −0.59 ± 0.40 −0.90 ± 0.48 0.020 −0.41 ± 0.32 −0.61 ± 0.35 0.047
Right ventricle Left ventricle
EDVi (ml/m2) 117.54 ± 58.10 76.13 ± 16.97 b0.001 72.35 ± 10.42 76.60 ± 10.19 0.172
ESVi (ml/m2) 66.85 ± 40.00 36.22 ± 9.09 b0.001 29.64 ± 6.82 28.81 ± 8.14 0.708
EF total (%) 44.77 ± 8.33 52.99 ± 5.23 b0.001 59.07 ± 7.50 62.75 ± 7.67 0.281
Longitudinal strain (εl (%)) −13.48 ± 6.26 −19.66 ± 3.60 b0.001 −15.67 ± 4.96 −18.37 ± 4.78 0.067
Circumferential strain (εc (%)) −17.61 ± 4.63 −17.81 ± 3.13 0.870
Radial strain (εr (%)) 25.65 ± 9.83 28.22 ± 9.75 0.378
P-value from t-test or Mann-Whitney-U test, bold p-values indicate statistical signiﬁcance.
EA: Ebstein's Anomaly; AVI: atrial volume, indexed; EF: ejection fraction; indexed; ε: strain; SR: strain rate; EDVi: end-diastolic volume, ESVi: end-systolic volume, indexed;
εc: circumferential strain; εr: radial strain.
Table 2
Correlation of right atrial and ventricular volumes and functional indexes from MR with
heart failure parameters of EA patients.
R/L-Volume-Index NYHA BNP
Right atrium
Reservoir function
Strain (εs) −0.449 (0.019) −0.446 (0.015) −0.637 (b0.001)
Strain rate (SRs) n.s. −0.345 (0.067) −0.487 (0.009)
Conduit function
Strain (εe) −0.416 (0.031) n.s. −0.516 (0.005)
Strain rate (SRe) −0.400 (0.039) n.s. n.s.
Booster pump function
Strain (εa) n.s. −0.560 (0.002) −0.420 (0.026)
Strain rate (SRa) n.s. −0.476 (0.009) −0.409 (0.031)
Right ventricle
EDVi 0.844 (b0.001) n.s. n.s.
ESVi 0.918 (b0.001) n.s. n.s.
EF −0.670 (b0.001) n.s. n.s.
Strain (εl) −0.644 (b0.001) −0.466 (0.012) −0.395 (0.042)
Spearman's correlation coefﬁcient (p-value), n.s.: non-signiﬁcant.
RAVI: right atrial volume, indexed; EF: ejection fraction; ε: strain; SR: strain rate; EDVi:
end-diastolic volume, ESVi: end-systolic volume, indexed; R/L-Volume-Index: Total
Right/Left-Volume-Index; NYHA: New York Heart Association classiﬁcation; BNP: brain
natriuretic peptide.
Table 3
Correlation of right atrial strain parameters with right ventricular volumes and functional
indexes from MR of EA patients.
EDVi ESVi RV EF RV Ell
Right atrium
Reservoir function
Strain (εs) n.s. n.s. n.s. 0.660 (b0.001)
Strain rate (SRs) n.s. n.s. n.s. 0.460 (0.014)
Conduit function
Strain (εe) n.s. n.s. n.s. 0.518 (0.005)
Strain rate (SRe) n.s. n.s. n.s. 0.474 (0.011)
Booster pump function
Strain (εa) n.s. n.s. n.s. n.s.
Strain rate (SRa) n.s. n.s. n.s. n.s.
Spearman's correlation coefﬁcient (p-value), n.s.: non-signiﬁcant.
ε: strain; SR: strain rate; EDVi: end-diastolic volume, ESVi: end-systolic volume, indexed.
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To discern the role of the RA conduit function further, CMR-FT
analysis of both the RA and aRV would be necessary. However, since
CMR-FT relies on tracking myocardial borders and the aRV lies within
the fRV only separated from it by the malformed TV, there are no
myocardial borders that can be tracked by CMR-FT. This makes
CMR-FT analysis of the aRV technically impossible.
Finally, age-wise maturation of atrial function have been reported in
the echocardiography literature [30]. Due to the rarity of the disease and
the small patient numbers available, effects of age on atrial function
have not been accounted for in the present study.
5. Conclusion
Right atrial and ventricular myocardial strain and strain rate are re-
duced in EA and can be reliably quantiﬁed using CMR-FT. CMR derived
longitudinal right atrial and ventricular strain appear to be markers of
heart failure in EA, since a close correlation of these parameters with
NYHA class, BNP and R/L-Volume-Index was observed. Alterations in
LA function were also noted. Incorporating atrial and ventricular defor-
mation indices into CMR assessment may help to improve themanage-
ment and decision making for intervention or operation in EA patients.
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